Stay updated on NKTR-214 Combo with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the NKTR-214 Combo with Nivolumab Clinical Trial page.

Latest updates to the NKTR-214 Combo with Nivolumab Clinical Trial page
- Check3 days agoChange DetectedAdded a new PubMed citation to Publications From PubMed: 'Next-Generation Immune Checkpoints and Tumor Microenvironment Modulation in Cancer Immunotherapy' (J Immunol Res, 2026).SummaryDifference0.0%

- Check10 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the page.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedGastric cancer was added to the study’s conditions and the page revision was updated to v3.4.2 (replacing v3.4.1).SummaryDifference0.1%

- Check39 days agoChange DetectedA minor site revision updated from v3.4.0 to v3.4.1. No core content or functionality changes were observed on the study details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check54 days agoChange DetectedMinor UI and labeling updates were applied, including glossary controls (Show/Hide glossary), capitalization tweaks (Last Update Submitted that Met QC Criteria; No FEAR Act Data vs data), and a new Revision: v3.4.0 tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check61 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No visible changes to the study content or its presentation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to NKTR-214 Combo with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NKTR-214 Combo with Nivolumab Clinical Trial page.